PGE2 and Poloxamer Synperonic F108 Enhance Transduction of Human HSPCs with a β-Globin Lentiviral Vector

Lentiviral vector (LV)-based hematopoietic stem and progenitor cell (HSPC) gene therapy is becoming a promising alternative to allogeneic stem cell transplantation for curing genetic diseases. Clinical trials are currently underway to treat sickle cell disease using LVs expressing designed anti-sick...

Descripción completa

Detalles Bibliográficos
Autores principales: Masiuk, Katelyn E., Zhang, Ruixue, Osborne, Kyle, Hollis, Roger P., Campo-Fernandez, Beatriz, Kohn, Donald B.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477655/
https://www.ncbi.nlm.nih.gov/pubmed/31024981
http://dx.doi.org/10.1016/j.omtm.2019.03.005

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6477655/
https://www.ncbi.nlm.nih.gov/pubmed/31024981
http://dx.doi.org/10.1016/j.omtm.2019.03.005

Ejemplares similares